Search

everythinglearnresearchcommunity

for

Search:↓

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

Tyrosinase and gp100 proteins can help diagnose and treat melanoma.

Non-viral delivery systems and stimuli-responsive nanoformulations can improve CRISPR-Cas9 gene therapy.

A brain-made hormone can protect against memory-related brain damage caused by harmful proteins.

Blue-light activation of TrkA improves hair-follicle stem cells' ability to become neurons and glial cells.

Pimecrolimus boosts melanin production and movement of skin pigment cells.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Immune cells boost stem cell activity in hairy moles, causing more hair growth.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Tofacitinib helped regrow hair in a woman with alopecia areata.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Combining traditional Chinese medicine with microneedles shows promise for effectively treating skin diseases with fewer side effects.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Cell therapy is advancing with stem cell transplants and genetically modified cells improving treatment for diseases like cancer and autoimmune disorders.

Liposomal delivery systems improve drug absorption through the skin, offering potential for better treatments.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

Hydrogel microneedles offer a promising, minimally invasive way to treat diseases like cancer and hair loss, but need improvements in strength and standardization.

Researchers developed a new skin patch that delivers more finasteride into the skin, potentially improving treatment for hair loss and prostate issues.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

The treatment was effective for lupus nephritis with manageable side effects.